Opinion|Videos|October 7, 2025

Multidisciplinary Team Approach to Atopic Dermatitis: Diagnosis and Coordinated Care Strategies

Experts discuss the importance of a multidisciplinary approach in managing pediatric atopic dermatitis (AD), highlighting the need for collaborative care, accurate diagnosis, psychosocial support, and long-term personalized strategies to address the disease’s complex physical and emotional burden.

This segment of the panel emphasized the critical role of a multidisciplinary approach in managing pediatric AD. Given the broad impact of the disease—ranging from allergic and pulmonary comorbidities to significant psychosocial strain—effective care often requires collaboration across various specialties. Dermatologists play a foundational role in establishing an accurate diagnosis and initiating treatment. However, referrals to allergists, pulmonologists, and even ear, nose, and throat specialists may be necessary for comprehensive care. Pharmacists and social workers also become vital team members, particularly in navigating insurance hurdles and improving access to medications. For families dealing with the emotional and logistical burdens of chronic pediatric illness, behavioral therapists are essential in supporting both children and caregivers.

The panel also discussed the complexity of diagnosing AD, noting that although it is common—affecting approximately 1 in 5 children—it often presents in nuanced ways. Early onset, typically beginning in infancy, involves chronic itch and inflamed, dry skin, though location and severity vary by age. Differentiating AD from other skin conditions, such as allergic contact dermatitis or psoriasis, can be challenging, especially in patients with exposure to irritants such as cosmetics or fragrances. There is no definitive blood test for AD, making it a clinical diagnosis based on patient history and physical examination. The panel acknowledged that modern advancements, including artificial intelligence tools, may soon aid in predicting flares, but for now, diagnosis and treatment remain largely observational and symptom driven.

Finally, the group reflected on the emotional toll of AD’s chronic and relapsing nature. Families often live in anticipation of the next flare, even during periods of skin clarity. This ever-present anxiety adds another layer to disease burden, distinguishing AD from other dermatologic conditions such as acne. The unpredictable waxing and waning course of the disease reinforces the importance of long-term, personalized treatment strategies, effective education, and psychosocial support to enhance outcomes for pediatric patients and their families.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Latest CME

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo